FDA Targets Anti-Generic Foot-Dragging By Big Drugmakers

The U.S. Food and Drug Administration on Thursday explained when it will exempt generic-drug makers from having to share special safety measures with brand-name rivals, in the agency's latest effort to...

Already a subscriber? Click here to view full article